Nitco reports consolidated net loss of Rs 2.85 crore in the March 2025 quarter
Sales rise 30.37% to Rs 93.19 crore
Net Loss of Nitco reported to Rs 2.85 crore in the quarter ended March 2025 as against net loss of Rs 54.94 crore during the previous quarter ended March 2024. Sales rose 30.37% to Rs 93.19 crore in the quarter ended March 2025 as against Rs 71.48 crore during the previous quarter ended March 2024.
For the full year,net loss reported to Rs 741.15 crore in the year ended March 2025 as against net loss of Rs 162.97 crore during the previous year ended March 2024. Sales declined 3.11% to Rs 312.92 crore in the year ended March 2025 as against Rs 322.97 crore during the previous year ended March 2024.
Particulars Quarter Ended Year Ended Mar. 2025 Mar. 2024 % Var. Mar. 2025 Mar. 2024 % Var. Sales 93.1971.48 30 312.92322.97 -3 OPM % -6.60-30.20 - -11.10-13.27 - PBDT 0.65-46.21 LP -91.57-133.54 31 PBT -2.90-53.47 95 -279.35-162.70 -72 NP -2.85-54.94 95 -741.15-162.97 -355
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
an hour ago
- Economic Times
Positive on market; buy these 2 stocks now: Rajesh Bhosale
Synopsis Angel One's Rajesh Bhosale is optimistic about the market. He advises holding a positive view above 24,700. The targets are 25,000 and 25,200. Bhosale recommends buying Glenmark Pharma, citing its strong performance. He also suggests purchasing Bharti Airtel, noting its upward trend. These stocks show promise. The market displays resilience amid geopolitical concerns. Focus on specific stock actions is key. Rajesh Bhosale, Equity Technical Analyst, Angel One, notes the market's cautious trading but relative strength, holding above 24,700. He suggests maintaining a positive outlook as long as this level holds, targeting 25,000 and then 25,200. Bhosale recommends buying Glenmark Pharma, citing its outperformance and continuation pattern breakout, and Bharti Airtel, highlighting its higher top higher bottom formation. ADVERTISEMENT The geopolitical tensions persist, but Nifty is holding on to the 24,900 level. What do you make of it? Rajesh Bhosale: Markets are trading cautiously, but as compared to the newsflow, we are showing relative strength. In fact, since last week, the market is holding on to 24,700 and in fact, the Nifty midcap space is already trading around its Friday's high. So, yes, the market is trading on a cautious note, but stock specific actions are being witnessed. So, as long as 24,700 level holds, one should maintain positive and on the higher side, 25,000 would be a key level and once that is breached, we would probably move towards 25,200 levels. What are the stock specific recommendations which you have and what are the stocks as well as sectors on your radar? Rajesh Bhosale: My first buy call is on Glenmark Pharma. The pharma space has been underperforming, but Glenmark Pharma has stood out. In fact, from the June lows, the stock has moved from Rs 1350 level to somewhere around Rs 1630, 1650 levels. So, bias is positive. In fact, on the daily chart, we are seeing a continuation pattern breakout and also its January swing high is taken out. So, we have a strong bias on Glenmark Pharma for outperformance, somewhere trading around Rs 1700, can be bought with a Rs 1640 as a stop loss and the near-term target would be Rs 1795. My second buy call is also on an outperformer – Bharti Airtel. The stock is continuously moving in a higher top higher bottom formation and after the last one month of consolidation, we are seeing that the May swing high has been taken out. So, Bharti Airtel looks strong with a stop loss of Rs 1917 can be bought. The near-term target that we are expecting is Rs 2,000 levels. (You can now subscribe to our ETMarkets WhatsApp channel) Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Nikita Papers IPO opens on May 27, price band set at Rs 95-104 per share Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Why gold prices could surpass $4,000: JP Morgan's bullish outlook explained Cyient shares fall over 9% after Q4 profit declines, core business underperforms Cyient shares fall over 9% after Q4 profit declines, core business underperforms L&T Technology Services shares slide 7% after Q4 profit dips L&T Technology Services shares slide 7% after Q4 profit dips Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? Trump-Powell standoff puts U.S. Rate policy in crosshairs: Who will blink first? SEBI warns of securities market frauds via YouTube, Facebook, X and more SEBI warns of securities market frauds via YouTube, Facebook, X and more API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders API Trading for All: Pi42 CTO Satish Mishra on How Pi42 is Empowering Retail Traders Security, transparency, and innovation: What sets Pi42 apart in crypto trading Security, transparency, and innovation: What sets Pi42 apart in crypto trading Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains Bitcoin, Ethereum, or Altcoins? How investors are structuring their crypto portfolios, Avinash Shekhar explains The rise of Crypto Futures in India: Leverage, tax efficiency, and market maturity, Avinash Shekhar of Pi42 explains NEXT STORY
Economic Times
an hour ago
- Economic Times
Kalpataru IPO opens today. Should you subscribe to this Rs 1,590-crore issue?
Kalpataru, a leading real estate developer with a dominant presence in the Mumbai Metropolitan Region (MMR), is opening its Rs 1,590 crore Initial Public Offering (IPO) today, June 24. The issue, priced in the range of Rs 387 to Rs 414 per share, will close on June 26. It comprises a 100% fresh issue of 3.84 crore shares. Ahead of the issue opening, the GMP on the shares of the company stood at Rs 5. ADVERTISEMENT The proceeds will primarily be used for repaying borrowings of the company and its subsidiaries, to the tune of Rs 1,193 crore. Post-issue, promoter shareholding will drop from 100% to 81.3%. Shares are expected to list on the bourses on July 1. Founded in 1988, Kalpataru has developed over 25.9 million sq. ft. across Mumbai, Thane, Pune, Hyderabad, and other cities. It operates under the Kalpataru Group, known for its infrastructure and EPC expertise. Kalpataru focuses predominantly on high-end and luxury residential projects and holds land reserves of over 1,886 acres across Maharashtra, Gujarat, and Rajasthan. As of December 2024, it had 25 ongoing, six forthcoming, and five planned projects spanning 49 million sq. ft., with 95% of its portfolio concentrated in MMR and Pune. The company is also expanding through joint ventures and redevelopment in land-scarce MMR a strong project pipeline and brand value, the company reported low profitability—posting a PAT margin of just 0.3% and an ROE of 0.4% in 9MFY25. Adjusted EBITDA margin stood at 31.8%, but reported EBITDA was just 5%. Analysts cite high capitalised interest and a change in revenue recognition policy for the tepid profitability. ADVERTISEMENT At the upper band, the IPO values Kalpataru at 186.3x EV/EBITDA (FY25), significantly above sector averages. SBI Securities and KR Choksey have both assigned a "Neutral" rating to the IPO, citing high debt, valuation concerns, and the need for sustained pre-sales traction post-listing to justify the may adopt a wait-and-watch approach until post-listing performance offers clarity on growth execution and deleveraging. ADVERTISEMENT (Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times) (You can now subscribe to our ETMarkets WhatsApp channel)
Economic Times
an hour ago
- Economic Times
Global Civil Projects IPO opens today: Check price band, GMP, subscription and other details
Investors can bid for a minimum of 211 shares per lot, translating into an investment of Rs 14,981 at the upper end. Global Civil Projects' Rs 119 crore IPO opens for subscription today, with a price band of Rs 67–71 per share. The Delhi-based EPC player, focused on government urban infrastructure, plans to use the proceeds for working capital, machinery purchase, and strategic expansion. Strong order book and improving margins back the 'Subscribe' call from Ventura Securities. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Should you subscribe? The Rs 119 crore initial public offering (IPO) of Global Civil Projects Ltd opens for subscription today and will close on June 26. The Delhi-based infrastructure EPC firm , with a focus on government contracts for urban infrastructure such as roads, bridges, flyovers, and sewerage systems, is offering 1.67 crore fresh equity shares in the price band of Rs 67–71 per can bid for a minimum of 211 shares per lot, translating into an investment of Rs 14,981 at the upper end. Ahead of the issue opening, the GMP is Rs company plans to use the proceeds to fund working capital requirements (Rs 75 crore), purchase construction machinery (Rs 14.3 crore), and for general corporate purposes, including potential acquisitions (Rs 29.7 crore). The equity shares will be listed on both the NSE and of FY24, Global Civil Projects has executed over 55 projects and has an outstanding order book of over Rs 900 crore. The company reported revenue of Rs 334.8 crore and net profit of Rs 15.4 crore in FY24, with PAT rising over 216% margin stood at 14.13%, and return on equity improved to 19.8%. Post-issue, promoter holding will come down from 88.1% to 63.4%.Ventura Securities has given a 'Subscribe' rating to the IPO, citing the company's execution capabilities, improving profitability, and strong presence in public infrastructure. 'With a track record of timely execution and a robust government pipeline, GCP is well-placed to scale,' the brokerage flagged risks such as geographical concentration and subcontractor dependency but noted that rising public capex and the company's positioning make it a credible long-term opportunity.: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
